Cyrus Biotechnology, Inc. research brief
CIK 1641241
Generated Nov. 17, 2026, 1:16 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: SEATTLE Washington. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- May 8, 2026 · D/A · 0001641241-26-000001 · Source evidence
Reported offering amount: 3000000 USD. Reported amount sold: 1481812 USD.
- July 16, 2025 · D · 0001641241-25-000003 · Source evidence
Reported offering amount: 1500000 USD. Reported amount sold: 1110000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Cyrus Biotechnology, Inc. research brief,” CIK 1641241, retrieved Nov. 17, 2026, 1:16 a.m.. Cite the specific accessions used. No amounts have been summed.